Joseph W. LaPlume, EVP, Corporate Strategy & Develop at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL), sold 3,856 shares at $290.83 ($1.1M) on 2022-02-22, disclosed to the SEC on 2022-02-23.
Seasonal sale ($1.1M) by EVP, Corporate Strategy & Develop — this insider has traded CRL in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 150 | $0 | 0.0% |
| 2 | $291.80 | 1,143 | $334K | 30.9% |
| 3 | $291.80 | 1,143 | $334K | 30.9% |
| 4 | $290.81 | 4 | $1K | 0.1% |
| 5 | $290.83 | 392 | $114K | 10.6% |
| 6 | $290.83 | 392 |
| $114K |
| 10.6% |
| 7 | $293.61 | 317 | $93K | 8.6% |
| 8 | $289.58 | 315 | $91K | 8.4% |
| Total | $280.22 avg | 3,856 | $1.1M | 100% |
| Filing → |
| CRL | SELL | 2025-08-20 | $126K | — | Filing → |
| CRL | SELL | 2025-08-08 | $60K | — | Filing → |
| CRL | SELL | 2025-05-15 | $73K | — | Filing → |